From GE Healthcare;;
Optison is the first 'second generation USCA' marketed in the US.
Ultrasound contrast agents used during an ultrasound imaging procedure, enable more accurate diagnosis of the patient's heart condition. The application of Optison allows to image the endocardial borders of the heart, to see cardiac wall motion abnormalities and to guide the selection and monitoring of treatment.
Optison represents a class of microbubbles with a shell formed by sonicating a solution of capsules filled with a perfluoropropane gas. The high molecular weight slows microbubble dissolution and prolongs the enhancement for several minutes. The human albumin-stabilized cavitation bubbles have a surface tension of 0.9 N/m and a surface dilatational viscosity 0.08 msP.

'August 06, 2001 Molecular Biosystems Inc., a subsidiary of Alliance Pharmaceutical Corp, announced the amendment of the Optison Product Rights Agreement (OPRA) dated May 9, 2000 with Mallinckrodt Inc, a unit of Tyco Healthcare. Optison, an intravenous ultrasound contrast agent, was developed by MBI and is being marketed by Mallinckrodt in the U.S. and Europe. Under the amended agreement, MBI will receive an immediate cash payment plus additional unspecified royalties for a two-year period. The amendment of OPRA coincides with an announcement by Nycomed Amersham Imaging that Nycomed and Mallinckrodt will terminate their joint commercialization and development agreement for ultrasound contrast agents, including Optison, effective Dec. 31, 2001. Effective Jan. 1, 2002, all selling and marketing activities will be resumed solely by Nycomed Amersham.'

Perfluorochemicals are used as microbubble filling gases because of their low solubility in blood and high vapor pressure. Various types of perfluorochemical gases like perfluorocarbon, perfluorobutane, perfluoropropane, and perfluorohexane are used to substitute the air in microbubbles to improve the stability and plasma longevity of the agents. Perfluorocarbons are liquids at room temperature but gas at body temperature. The large molecules of perfluorocarbons have slow diffusion and solubility which increase the enhancement time of the ultrasound contrast agent as compared to air.

See also Filling Gas, and PESDA.

The persistence of microbubbles is depended of the shell stability and the density of the gas.
This is defined by the equation:
(R x d)/(DIFS x const_sat)
where R is the bubble radius, d the gas density, DIFS the gas diffusivity and const_sat the saturation constant.
Microbubbles are stabilized with thin coatings of substances such as palmitic acid or by encapsulation in microspheres made with albumin, lipids, or polymers. Low-solubility low-diffusibility gases dramatically improve the persistence. Most recently developed ultrasound contrast agents combine these two approaches to prolong contrast enhancement.
Persistence is also a type of temporal smoothing used in both gray scale and color Doppler imaging. Successive frames are averaged as they are displayed to reduce the variations in the image between frames, hence lowering the temporal resolution of the image.

From Medison Co.,Ltd.;
'The SONOACE 9900 offers exceptional B/W image clarity by newly developed FINE™ Filter technology, which contributes to edge enhancement and average filtering in real-time. OSIO™(Organ Specified Image Optimization)sets the best diagnosis environment with minimum manual operation and increases patient throughput. Also, color images are improved with better color Doppler performance, high color sensitivity, fine pixel image, and reduced flash artifact across all probes.'

'The SONOACE 9900 PRIME from Medison offers full range of applications specially designed for your practice. With the addition of the new C-Square Processing and PSAD Beamformer, SONOACE 9900 PRIME provides higher contrast resolution and clearer image quality in all application ranges. Based on super clear image resolution and versatile 3D functions, SONOACE 9900 PRIME offers you the true value of future ultrasound technology.'

From Siemens Medical Systems;
'The SONOLINE G20™ ultrasound system quickly distances itself from the competition with next-generation all-digital system architecture that utilizes Siemens technology migration. Individual imaging parameters have been optimized for a wide variety of clinical applications and patient types. So you can realize a higher degree of diagnostic confidence. Without doubt.'